| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniel Chandler | Q88270151 |
| P2093 | author name string | Olga Borodovitsyna | |
| Matthew Flamini | |||
| P2860 | cites work | Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness | Q40217476 |
| A systematic review of the prevalence of schizophrenia | Q21144720 | ||
| A protein factor essential for microtubule assembly | Q22010837 | ||
| The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis | Q22241865 | ||
| Alzheimer's Disease | Q22248111 | ||
| Maintenance treatment with antipsychotic drugs for schizophrenia | Q24197902 | ||
| Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deficient mice impairs the functionality of the forebrain clock and affects nociception | Q24556568 | ||
| Molecular pathology of schizophrenia: more than one disease process? | Q24676503 | ||
| Long-lasting, selective, anxiogenic effects of feline predator stress in mice. | Q48510710 | ||
| α1-Adrenoceptors in the hippocampal dentate gyrus involved in learning-dependent long-term potentiation during active-avoidance learning in rats. | Q48526071 | ||
| Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task. | Q48624607 | ||
| Long-term increases in the evoked population spike in the CA1 region of rat hippocampus induced by beta-adrenergic receptor activation | Q48685123 | ||
| The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice. | Q48703792 | ||
| Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. | Q48835886 | ||
| Neuromelanin and Parkinson's disease | Q48839752 | ||
| Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study. | Q48946404 | ||
| Locus coeruleus and regulation of behavioral flexibility and attention. | Q50312061 | ||
| Catecholaminergic neuronal network dysfunction in the frontal lobe of a genetic mouse model of schizophrenia. | Q50569566 | ||
| Impairment of the tyrosine hydroxylase neuronal network in the orbitofrontal cortex of a genetically modified mouse model of schizophrenia. | Q51014450 | ||
| Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice. | Q51029305 | ||
| Treatment with the noradrenergic alpha-2 agonist clonidine, but not diazepam, improves spatial working memory in normal young rhesus monkeys. | Q51437675 | ||
| Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task. | Q51996917 | ||
| Reward expectation, orientation of attention and locus coeruleus-medial frontal cortex interplay during learning. | Q52088645 | ||
| Increased noradrenaline levels in CSF and plasma of schizophrenic patients. | Q52098436 | ||
| Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings. | Q52120927 | ||
| Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. | Q52248519 | ||
| Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial. | Q53752158 | ||
| The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes | Q55921579 | ||
| Factors associated with increased noradrenaline levels in schizophrenic patients | Q60642726 | ||
| Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress | Q63243647 | ||
| Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease | Q67218667 | ||
| Sleep disturbance in acute schizophrenic patients | Q68605090 | ||
| Alpha methyldopa-chlorpromazine interaction in schizophrenic patients | Q69382720 | ||
| DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison | Q70151142 | ||
| Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice | Q71894694 | ||
| Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs | Q72565841 | ||
| Noradrenergic responses in rat hippocampus: Evidence for mediation by α and β receptors in the in vitro slice | Q72893829 | ||
| DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neurons | Q72898375 | ||
| Excitability increase induced by beta-adrenergic receptor-mediated activation of hyperpolarization-activated cation channels in rat cerebellar basket cells | Q73054534 | ||
| Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors | Q73960224 | ||
| Norepinephrine exhibits two distinct profiles of action on sensory cortical neuron responses to excitatory synaptic stimuli | Q73986058 | ||
| The locus coeruleus and noradrenergic modulation of cognition | Q37384698 | ||
| Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats | Q37451932 | ||
| Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction | Q37557593 | ||
| Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis | Q37627302 | ||
| Exercise-induced noradrenergic activation enhances memory consolidation in both normal aging and patients with amnestic mild cognitive impairment | Q37634197 | ||
| Microglia and inflammation in Alzheimer's disease | Q37703295 | ||
| Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease | Q37794466 | ||
| Catecholamine modulation of prefrontal cortical cognitive function | Q37827944 | ||
| Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia | Q37846278 | ||
| Antipsychotics in the treatment of schizophrenia: an overview | Q37973145 | ||
| Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling | Q38302843 | ||
| Atomoxetine facilitates attentional set shifting in adolescent rats | Q38392501 | ||
| Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system | Q38770352 | ||
| Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease | Q38875190 | ||
| β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory. | Q38902841 | ||
| Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants | Q39921762 | ||
| Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart | Q40026474 | ||
| Disease-specific patterns of locus coeruleus cell loss | Q41102223 | ||
| Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea | Q41158228 | ||
| Hippocampal long-term potentiation that is elicited by perforant path stimulation or that occurs in conjunction with spatial learning is tightly controlled by beta-adrenoreceptors and the locus coeruleus. | Q41332356 | ||
| Noradrenergic function in schizophrenia | Q41464078 | ||
| Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients | Q41516104 | ||
| Modulation of the perforant path-evoked potential in dentate gyrus as a function of intrahippocampal β-adrenoceptor agonist concentration in urethane-anesthetized rat. | Q41880409 | ||
| Norepinephrine and ß₁-adrenergic signaling facilitate activation of hippocampal CA1 pyramidal neurons during contextual memory retrieval | Q41884729 | ||
| Amelioration of deficit syndrome of schizophrenia by norepinephrine reuptake inhibitor | Q41957493 | ||
| PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research | Q42078583 | ||
| Locus Coeruleus Stimulation Facilitates Long-Term Depression in the Dentate Gyrus That Requires Activation of β-Adrenergic Receptors | Q42225004 | ||
| Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis | Q42259951 | ||
| Schizophrenia: elevated cerebrospinal fluid norepinephrine | Q42271329 | ||
| Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism | Q42498468 | ||
| Cellular mechanisms of long-term depression induced by noradrenaline in rat prefrontal neurons | Q43077655 | ||
| Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting | Q43211242 | ||
| Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness | Q43227336 | ||
| Subtypes of adrenergic receptors and intracellular mechanisms involved in modulatory effects of noradrenaline on glutamate | Q43580969 | ||
| Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. | Q43940137 | ||
| Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? | Q44543032 | ||
| The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro | Q44653494 | ||
| Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity | Q44775530 | ||
| The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years | Q44801054 | ||
| The effects of tonic locus ceruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat. | Q45170156 | ||
| Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys | Q45225964 | ||
| Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus | Q46341745 | ||
| The locus coeruleus in schizophrenia: a postmortem study of noradrenergic neurones | Q46383661 | ||
| Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. | Q46528311 | ||
| Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability | Q46812059 | ||
| Norepinephrine provides short-term neuroprotection against Aβ1-42 by reducing oxidative stress independent of Nrf2 activation | Q46875809 | ||
| Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. | Q46904762 | ||
| TMT predator odor activated neural circuit in C57BL/6J mice indicates TMT-stress as a suitable model for uncontrollable intense stress | Q47768940 | ||
| α-Adrenergic receptors in auditory cue detection: α2 receptor blockade suppresses false alarm responding in the rat. | Q48013660 | ||
| PI3Kγ is required for NMDA receptor-dependent long-term depression and behavioral flexibility | Q48034381 | ||
| Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. | Q48093265 | ||
| Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. | Q48116588 | ||
| Origin, distribution, and morphology of galaninergic fibers in the rodent trigeminal system | Q48158081 | ||
| Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage | Q48165305 | ||
| Brain noradrenergic receptors in major depression and schizophrenia | Q48179741 | ||
| Methylphenidate Enhances Early-Stage Sensory Processing and Rodent Performance of a Visual Signal Detection Task | Q48183539 | ||
| Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain | Q48194930 | ||
| Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function | Q48303117 | ||
| Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease | Q48332119 | ||
| Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease | Q48337593 | ||
| Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy | Q48387778 | ||
| Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering | Q48401808 | ||
| Locus ceruleus regulates sensory encoding by neurons and networks in waking animals. | Q48411465 | ||
| Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. | Q48419219 | ||
| Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. | Q48427318 | ||
| Phasic activation of the locus coeruleus enhances responses of primary sensory cortical neurons to peripheral receptive field stimulation. | Q48450769 | ||
| Dopamine β-Hydroxylase Activity in Brains of Chronic Schizophrenic Patients | Q48479569 | ||
| Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. | Q48485351 | ||
| Effects of noradrenaline on neuronal NOS2 expression and viability. | Q48498260 | ||
| Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist. | Q48498266 | ||
| Selective noradrenaline depletion impairs working memory and hippocampal neurogenesis. | Q48505722 | ||
| Adrenergic pharmacology and cognition: focus on the prefrontal cortex | Q24684217 | ||
| Alzheimer's disease: genes, proteins, and therapy | Q28131806 | ||
| The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 | ||
| Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies | Q28215775 | ||
| Orienting and reorienting: the locus coeruleus mediates cognition through arousal | Q28276475 | ||
| The worldwide prevalence of ADHD: a systematic review and metaregression analysis | Q28304626 | ||
| Cocaine-induced psychosis | Q28325040 | ||
| A distinct role for norepinephrine in memory retrieval | Q28508141 | ||
| Parkinson's disease: mechanisms and models | Q29547424 | ||
| Epidemiology of Parkinson's disease | Q29614901 | ||
| Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology | Q29617284 | ||
| Effects of intracerebroventricular corticotropin releasing factor on sensory-evoked responses in the rat visual thalamus | Q30412826 | ||
| Redundant catecholamine signaling consolidates fear memory via phospholipase C. | Q30464844 | ||
| Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating | Q30466233 | ||
| Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia | Q30574170 | ||
| Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease | Q30835713 | ||
| Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices | Q33606903 | ||
| Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies | Q33703950 | ||
| A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat | Q33768657 | ||
| Through the looking glass: differential noradenergic modulation of prefrontal cortical function | Q33857752 | ||
| Proposal for a noradrenaline hypothesis of schizophrenia | Q33981345 | ||
| The role of the locus coeruleus in the development of Parkinson's disease | Q34001587 | ||
| Ear2 deletion causes early memory and learning deficits in APP/PS1 mice | Q34101988 | ||
| Cognitive deficits in depression: possible implications for functional neuropathology | Q34169368 | ||
| Fronto-striatal cognitive deficits at different stages of Parkinson's disease | Q34296796 | ||
| The slow afterhyperpolarization: a target of β1-adrenergic signaling in hippocampus-dependent memory retrieval | Q34332796 | ||
| Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein | Q34345614 | ||
| Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST). | Q34464322 | ||
| Snaring the function of alpha-synuclein | Q34465204 | ||
| Set-shifting in children with autism spectrum disorders: reversal shifting deficits on the Intradimensional/Extradimensional Shift Test correlate with repetitive behaviors | Q34477719 | ||
| Impaired adrenergic-mediated plasticity of prefrontal cortical glutamate synapses in rats with developmental disruption of the ventral hippocampus | Q34499271 | ||
| Attention-deficit/hyperactivity disorder: a selective overview | Q34558447 | ||
| Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease | Q34572608 | ||
| Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. | Q34621253 | ||
| Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder | Q34624470 | ||
| Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility | Q34768889 | ||
| More is less: a disinhibited prefrontal cortex impairs cognitive flexibility | Q34777486 | ||
| Sensitivity of locus ceruleus neurons to reward value for goal-directed actions | Q35142934 | ||
| Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment | Q35210777 | ||
| The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. | Q35427654 | ||
| Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling | Q35436140 | ||
| Lack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling. | Q35604751 | ||
| Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? | Q35743680 | ||
| ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA | Q35869454 | ||
| Psychostimulants act within the prefrontal cortex to improve cognitive function | Q35870785 | ||
| The impact of hemodynamic stress on sensory signal processing in the rodent lateral geniculate nucleus | Q35929979 | ||
| Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates | Q35957721 | ||
| Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections | Q35985428 | ||
| Repeated stressor exposure enhances contextual fear memory in a beta-adrenergic receptor-dependent process and increases impulsivity in a non-beta receptor-dependent fashion | Q35988412 | ||
| Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior | Q36089383 | ||
| Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression | Q36110323 | ||
| Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice | Q36156959 | ||
| Association Study between Norepinephrine Transporter Gene Polymorphism and Schizophrenia in a Korean Population | Q36205444 | ||
| Network reset: a simplified overarching theory of locus coeruleus noradrenaline function | Q36258408 | ||
| Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance | Q36299557 | ||
| The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography. | Q36424492 | ||
| Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders | Q36445410 | ||
| Norepinephrine-mediated emotional arousal facilitates subsequent pattern separation | Q36453263 | ||
| Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice | Q36462902 | ||
| Noradrenergic control of error perseveration in medial prefrontal cortex | Q36499731 | ||
| Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. | Q36589254 | ||
| Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness | Q36792147 | ||
| Somatostatin and Alzheimer's disease | Q37116455 | ||
| Relation of locus coeruleus neurons in monkeys to Pavlovian and operant behaviors. | Q37131846 | ||
| Functional consequences of locus coeruleus degeneration in Alzheimer's disease | Q37184761 | ||
| Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. | Q37234586 | ||
| Neuroimaging of nonmotor features of Parkinson's disease. | Q37288377 | ||
| Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs | Q37307331 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | nervous system | Q9404 |
| alcohols | Q156 | ||
| amine | Q167198 | ||
| phenol | Q407142 | ||
| cognition | Q2200417 | ||
| cognitive disorder | Q3065932 | ||
| hydrocarbon | Q43648 | ||
| P304 | page(s) | 6031478 | |
| P577 | publication date | 2017-05-03 | |
| P1433 | published in | Neural Plasticity | Q15716605 |
| P1476 | title | Noradrenergic Modulation of Cognition in Health and Disease | |
| P478 | volume | 2017 |
| Q95936707 | Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology |
| Q47099589 | Analgesic Mechanisms of Antidepressants for Neuropathic Pain |
| Q64988170 | Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats. |
| Q90091988 | Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review |
| Q64086402 | Cortex-wide neural interfacing via transparent polymer skulls |
| Q50153540 | Disturbed Sleep and Diabetes: A Potential Nexus of Dementia Risk. |
| Q91852210 | Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication |
| Q58764052 | ErbB4 deletion in noradrenergic neurons in the locus coeruleus induces mania-like behavior via elevated catecholamines |
| Q64869644 | Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. |
| Q92932081 | Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndrome |
| Q55057253 | Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra. |
| Q90553009 | Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration |
| Q89106921 | Neurotransmitter modulation by the gut microbiota |
| Q49529875 | Norepinephrine in the Medial Pre-frontal Cortex Supports Accumbens Shell Responses to a Novel Palatable Food in Food-Restricted Mice Only. |
| Q89388742 | On the Developmental Timing of Stress: Delineating Sex-Specific Effects of Stress across Development on Adult Behavior |
| Q90220218 | Persistent Stress-Induced Neuroplastic Changes in the Locus Coeruleus/Norepinephrine System |
| Q64764582 | Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. |
Search more.